DSIP 30mg — Vial Spec, Reconstitution Math & COA

Overview and Availability: DSIP 30mg Mass Specifications

Delta-Sleep-Inducing Peptide (DSIP) is a well-characterized amphiphilic nonapeptide widely evaluated in neurochemical research for its influence on central sleep architecture, stress-axis regulation, and metabolic stabilization during deep rest states. When designing multi-animal preclinical cohorts or automated high-throughput assays, investigators frequently evaluate high-mass vial options such as a dsip 30mg specification to streamline diluent preparation and maintain consistent batch parameters across extended timelines.

To ensure optimal lyophilized stability and eliminate degradation risks associated with repeated container access, PX1 Research provides fully characterized research-grade formulations. While enterprise workflows often request 30mg volumetric fills, PX1 Research currently stocks standardized DSIP 5mg vials, which provide the optimal balance between high analytical purity, immediate solvent reconstitution, and stability control. Researchers seeking alternative mass configurations across our broader catalog can explore our full range of all peptides for standardized laboratory inventory.

Chemical Profile and Structure of Delta-Sleep-Inducing Peptide

DSIP is an endogenous peptide originally isolated from the cerebral venous blood of rabbits induced into delta-wave sleep via thalamic stimulation. Its primary amino acid sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE), yielding a molecular weight of approximately 848.81 g/mol. The presence of acidic amino acid residues (Asp and Glu) gives the nonapeptide a net negative charge at physiological pH, directly influencing its solubility kinetics in aqueous reagents.

The primary structural stability of DSIP depends on the preservation of its terminal tryptophan residue and central glycyl-aspartyl motif. In solid-phase peptide synthesis (SPPS), high-purity production yields a crystalline lyophilized cake requiring controlled moisture levels and inert atmosphere sealing. The physical matrix of a 30mg lyophilized cake requires targeted reconstitutive handling to prevent aggregation or hydrophobic secondary structure formation prior to assay deployment.

Preclinical Mechanisms: Delta-Wave Induction and Stress-Axis Modulation

In preclinical literature, DSIP is primarily investigated for its role as a neuromodulator of sleep architecture and hypothalamic-pituitary-adrenal (HPA) axis dynamics. Electrophysiological studies utilizing rodent EEG monitoring demonstrate that administration of exogenous DSIP promotes an increase in slow-wave sleep (SWS), specifically enhancing delta-wave spectral power without suppressing REM sleep phases.

In addition to sleep architecture, in vitro assays and animal models indicate that DSIP exerts a protective modulatory effect against acute stress induction. Preclinical data suggest that the peptide reduces baseline plasma corticosterone concentrations during systemic stress challenges by dampening hypothalamic corticotropin-releasing factor (CRF) release. This dual regulatory activity makes DSIP a central subject of study in metabolic recovery models and neuroendocrine stabilization research. Researchers exploring related central nervous system modulators often cross-reference these mechanisms against nonapeptides like Selank and bioregulatory signals like Epitalon.

Reconstitution Mathematics for 30mg Lyophilized Mass

Accurate concentration calculations are vital when reconstituting a large mass specification such as 30mg of lyophilized powder. The total volume of diluent added dictates the final working concentration (mg/mL or µg/µL), directly impacting micro-pipetting accuracy during assay loading.

The fundamental concentration formula applied in laboratory reconstitution is: Concentration (mg/mL) = Total Mass (mg) / Total Volume (mL).

Consider the following primary diluent volumes for a 30mg vial configuration:

1. Reconstitution with 1.0 mL Diluent: Yields a final concentration of 30.0 mg/mL (30.0 µg/µL). This high-density working stock is ideal for automated micro-dispensing systems where minimal fluid volume addition is required per reaction well.

2. Reconstitution with 2.0 mL Diluent: Yields a final concentration of 15.0 mg/mL (15.0 µg/µL). This moderate concentration balances volumetric precision with ease of pipette delivery across manual assay protocols.

3. Reconstitution with 3.0 mL Diluent: Yields a final concentration of 10.0 mg/mL (10.0 µg/µL). This standardized decade-based concentration simplifies aliquot dosing math across multi-subject animal protocols.

Researchers working with varying mass sizes or custom diluent fractions should utilize our dedicated laboratory reconstitution calculator to verify volumetric adjustments before executing liquid handling.

Aliquot Planning and Freeze-Thaw Prevention Strategy

Reconstituting a single large vial such as a 30mg mass batch presents structural risks if the solution undergoes multiple thermal transitions. Repeated freeze-thaw cycles induce shear stress, localized pH shifts, and molecular cleavage of sensitive peptide bonds, leading to loss of bioactivity.

To maximize structural integrity, laboratories receiving bulk or high-mass vials must execute a strict single-use aliquot workflow immediately following full dissolution:

1. Perform initial reconstitution under a laminar flow hood using sterile 0.9% bacteriostatic sodium chloride or bacteriostatic water.

2. Allow the vial to rest at room temperature for 5 to 10 minutes to ensure full solvation; do not vortex or subject to high-shear mechanical agitation.

3. Dispense the working solution into micro-centrifuge tubes pre-calibrated for single-assay volumes (e.g., 50 µL to 200 µL per tube).

4. Flash-freeze the secondary micro-vials using liquid nitrogen or an ultra-low temperature bath, then store at -20°C or -80°C until immediate use.

Following this procedure ensures that individual experimental aliquots undergo only one freeze-thaw event, preserving peptide structural integrity across multi-week testing schedules.

Analytical Quality Standards: ISO 17025 Certificate of Analysis

Quantifying purity and verifying sequence identity are non-negotiable prerequisites for valid, reproducible laboratory research. PX1 Research subjects every synthesis lot to independent, third-party analytical validation in an ISO 17025 accredited testing facility.

Every shipped unit is paired with a lot-matched certificate of analysis (COA) confirming the following critical parameters:

High-Performance Liquid Chromatography (HPLC): Confirms chemical purity by measuring peak area percentage. PX1 Research mandates a baseline target purity of ≥98.0%, ensuring minimal sequence truncation or residual synthesis byproducts.

Mass Spectrometry (MS): Electrospray ionization mass spectrometry (ESI-MS) or MALDI-TOF analysis verifies the exact molecular weight (848.81 g/mol expected for DSIP), confirming sequence correctness.

Endotoxin Quantitation: Reagent safety for cellular and animal models requires strict control over bacterial lipopolysaccharides. Every lot is subjected to Limulus Amebocyte Lysate (LAL) testing to guarantee endotoxin levels remain below 0.05 EU/mg.

Researchers can review batch documentation and download verifying reports directly through our dedicated COA access portal.

Comparative Analysis: DSIP alongside Recovery & Secretagogue Classes

In comprehensive recovery and neuroendocrine research frameworks, DSIP is often evaluated in conjunction with or alongside other structural peptide classes. Understanding how DSIP compares to secretagogue or regulatory peptides helps investigators structure clear control groups and comparative assay matrices.

While DSIP targets delta-wave electrophysiological sleep induction and dampens HPA-axis hyperreactivity, growth hormone secretagogues like CJC-1295 and growth hormone releasing peptides act via completely distinct pathways. CJC-1295 stimulates GHRH receptors on pituitary somatotropes to increase pulsatile growth hormone secretion, aiding tissue repair models. Similarly, the bioregulatory pineal peptide Epitalon regulates circadian melatonin release and telomerase expression rather than directly altering sleep-stage delta waves. Including these distinct compounds within comparative studies allows researchers to isolate specific signaling cascades involved in rest-phase physiological recovery.

Solvent Selection and Physical Stability Parameters

The selection of reconstitution diluent directly influences the chemical stability and storage lifespan of DSIP in liquid state. Depending on the intended experimental timeline, researchers must select appropriate solvent media:

Sterile Bacteriostatic Water (0.9% Benzyl Alcohol): Recommended for multi-dose micro-aliquot sampling over periods up to 28 days when maintained at 2°C to 8°C. The antimicrobial agent prevents microbial contamination in multi-entry vials.

Sterile 0.9% Sodium Chloride (Saline): Preferred for immediate in vivo rodent assays where antimicrobial preservatives like benzyl alcohol might introduce neurochemical artifacts or cellular toxicity.

Buffers (PBS, pH 7.4): Highly suited for in vitro biochemical assays requiring physiological pH buffer capacity. However, buffered solutions lacking antimicrobial agents must be used immediately or frozen into single-use aliquots.

Unreconstituted lyophilized DSIP powder should be stored desiccated at -20°C. Under these conditions, the solid-state nonapeptide demonstrates stability exceeding 24 months.

Institutional Supply Protocols and Bulk Acquisition

Large-scale research projects, university laboratories, and contract research organizations (CROs) frequently require consistent bulk access to standardized research compounds to minimize batch-to-batch variation across multi-year grant cycles.

PX1 Research maintains comprehensive inventory support for high-volume research applications. Qualified institutional accounts can establish customized delivery schedules, batch reservation, and custom fill specifications by visiting our institutional wholesale program portal. All institutional lots undergo identical USA manufacturing compliance, HPLC/MS identity validation, and endotoxin screening to support rigorous scientific standards.